Sai Life Sciences · NSE: SAILIFE · BSE: 544306
Q1 FY26 results · Apr–Jun 2025
Sai Life Sciences reported revenue from operations of ₹496.42 crore and net profit of ₹60.45 crore for Q1 FY26 (Apr–Jun 2025), on a consolidated basis.
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 496.42 | — | — | 579.51 | −14.3% |
| Other income | 9.90 | — | — | 9.60 | +3.2% |
| Total income | 506.32 | — | — | 589.11 | −14.1% |
| Profit before tax | 80.75 | — | — | 118.80 | −32.0% |
| Net profit for the period | 60.45 | — | — | 88.27 | −31.5% |
| EPS, basic (₹) | 2.90 | — | — | 4.24 | −31.6% |
| Net margin (%) | 12.2 | — | 15.2 |
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 483.04 | — | — | 567.01 | −14.8% |
| Other income | 10.01 | — | — | 9.82 | +1.9% |
| Total income | 493.04 | — | — | 576.83 | −14.5% |
| Profit before tax | 77.98 | — | — | 120.47 | −35.3% |
| Net profit for the period | 58.37 | — | — | 89.94 | −35.1% |
| EPS, basic (₹) | 2.80 | — | — | 4.32 | −35.2% |
| Net margin (%) | 12.1 | — | 15.9 |
Consolidated
- Filed with BSE
- 07 Aug 2025, 23:46 IST
- Board meeting
- 07 Aug 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Aug 2025, 23:46 IST
- Board meeting
- 07 Aug 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE